• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CRISPR Therapeutics AG - Common Shares (NQ:CRSP)

56.09 -0.17 (-0.30%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,992,285
Open 54.30
Bid (Size) 55.95 (4)
Ask (Size) 56.25 (1)
Prev. Close 56.26
Today's Range 53.70 - 56.78
52wk Range 30.04 - 71.13
Shares Outstanding 78,935,098
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
The 3 Things That Matter for CRISPR Therapeutics Now
July 29, 2025
As time marches on, the factors that could make or break this stock are becoming crystal clear. 
Via The Motley Fool
Cathie Wood's Ark Invest Loads Up On Absci, Offloads CRISPR Therapeutics
July 26, 2025
Ark Invest traded in VCYT, IRDM, CRSP, KTOS, ABSI, VEEV, ADPT, and GH. Mainly focused on healthcare innovation. 
Via Benzinga

Performance

YTD
+35.4%
+35.4%
1 Month
+8.6%
+8.6%
3 Month
+46.6%
+46.6%
6 Month
+34.9%
+34.9%
1 Year
+2.3%
+2.3%

More News

Read More
Cathie Wood Doesn't Need Tesla To Win—ARKK Delivers A Blowout While EV Giant Idles
July 25, 2025
Via Benzinga
Topics ETFs
3 Monster Stocks in the Making to Buy Right Now
July 21, 2025
Via The Motley Fool
Independent Bank Posts Upbeat Earnings, Joins Blaize Holdings, Interactive Brokers Group And Other Big Stocks Moving Higher On Friday
July 18, 2025
Via Benzinga
Topics Stocks
3 Monster Stocks to Hold for the Next 10 Years
July 17, 2025
Via The Motley Fool
CRISPR Stock Surges in Recent Weeks: What's Going On?
July 10, 2025
Via Benzinga
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers
July 09, 2025
Via Investor Brand Network
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers
July 09, 2025
Via FinancialNewsMedia
Topics Death
10 Monster Stocks to Hold for the Next 10 Years
July 08, 2025
Via The Motley Fool
Cathie Wood-Led Ark Launches Buffer ETFs For Its Flagship ARKK, Analyst Says It's Like Diet Soda — 50% Loss Protection, But There's A Catch
July 08, 2025
Via Benzinga
Topics ETFs
2 Beaten-Down Stocks With Massive Upside Potential
July 03, 2025
Via The Motley Fool
2 Growth Stocks to Buy Hand Over Fist in July
July 02, 2025
Via The Motley Fool
44 Public Companies Make Time's Most Influential List: Coinbase, UFC, Nintendo, Netflix And More Stocks Investors Can Buy
June 27, 2025
Via Benzinga
2 Biotech Stocks to Buy Before They Soar 84% and 240%, According to Certain Wall Street Analysts
June 21, 2025
Via The Motley Fool
FDA Halts Trials Exporting Americans' Cells To Hostile Countries For Genetic Engineering
June 20, 2025
Via Benzinga
The FDA Shake-Up Continues, And Could Impact Genetic Medicines
June 20, 2025
Via Investor's Business Daily
Topics Government
Eli Lilly's $1.3 Billion Verve Deal Signals Confidence In Gene Editing Space: Analyst
June 18, 2025
Via Benzinga
Jabil Posts Upbeat Earnings, Joins Verve Therapeutics, John Wiley & Sons And Other Big Stocks Moving Higher On Tuesday
June 17, 2025
Via Benzinga
Verve Therapeutics Skyrockets — Pulling Gene-Editing Stocks Higher — On $1.3 Billion Eli Lilly Takeover
June 17, 2025
Via Investor's Business Daily
Cathie Wood Just Flagged The Start Of A Biotech Revolution: These 2 Stocks With 10x Potential Are Leading It
June 09, 2025
Via Benzinga
Topics Artificial Intelligence
The Best Stocks to Invest $1,000 in Right Now
June 03, 2025
Via The Motley Fool
Topics Government World Trade
The 2 Smartest Beaten-Down Biotech Stocks to Buy on the Dip
June 02, 2025
Via The Motley Fool
Topics Economy
5 Monster Stocks to Hold for the Next 10 Years
May 20, 2025
Via The Motley Fool
Topics Artificial Intelligence
CRISPR Therapeutics Stock Could Double Your Money, According to Wall Street. Is It Time to Buy?
May 20, 2025
Via The Motley Fool

Frequently Asked Questions

Is CRISPR Therapeutics AG - Common Shares publicly traded?
Yes, CRISPR Therapeutics AG - Common Shares is publicly traded.
What exchange does CRISPR Therapeutics AG - Common Shares trade on?
CRISPR Therapeutics AG - Common Shares trades on the Nasdaq Stock Market
What is the ticker symbol for CRISPR Therapeutics AG - Common Shares?
The ticker symbol for CRISPR Therapeutics AG - Common Shares is CRSP on the Nasdaq Stock Market
What is the current price of CRISPR Therapeutics AG - Common Shares?
The current price of CRISPR Therapeutics AG - Common Shares is 56.09
When was CRISPR Therapeutics AG - Common Shares last traded?
The last trade of CRISPR Therapeutics AG - Common Shares was at 08/01/25 04:00 PM ET
What is the market capitalization of CRISPR Therapeutics AG - Common Shares?
The market capitalization of CRISPR Therapeutics AG - Common Shares is 4.43B
How many shares of CRISPR Therapeutics AG - Common Shares are outstanding?
CRISPR Therapeutics AG - Common Shares has 4B shares outstanding.
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap